Latest News

If you are wondering whether ABIVAX Société Anonyme is priced attractively after its huge run, or if the current share price already reflects the story, this article breaks down what the numbers say about value. The stock last closed at €109.40, with a 7 day return of 8.1%, a 30 day return showing a 0.9% decline, a year to date return showing a 4.9% decline, and a 1 year gain that is very large compared to where it started. Recent news coverage has focused on ABIVAX Société Anonyme as a high...

Wondering if Snap at around US$4.48 is a bargain or a value trap? This article will help you frame that question using several different valuation angles. The share price has faced heavy pressure, with a 44.9% decline year to date and a 52.0% decline over the last 12 months. Changes like this can influence how the market views both its growth potential and risk profile. Recent coverage has focused on Snap's position as a social media and messaging platform, its user engagement, and how it is...

Westgold Resources Limited has recently executed syndicated loan documentation for A$600,000,000 of unsecured revolving financing facilities with five Tier 1 lenders, alongside Board approval to expand the Higginsville Processing Hub from 1.6Mtpa to 2.6Mtpa following a positive Definitive Feasibility Study. Together, the new long-term, undrawn funding capacity and the Higginsville expansion decision point to a materially higher level of balance sheet flexibility and processing capability for...

SolarEdge Technologies (SEDG) grabbed attention after a 12.7% jump, as Jefferies and Bank of America upgraded the stock, citing a potential demand rebound, regained top U.S. inverter share and a stronger earnings outlook. See our latest analysis for SolarEdge Technologies. The sharp 13.29% 1 day share price return to US$51.73 sits on top of a 47.97% 30 day and 78.01% 90 day share price return. The 1 year total shareholder return of about 3x contrasts with a 5 year total shareholder return...

SEC approval puts Nasdaq’s tokenization plans in focus The SEC’s decision to let certain securities listed on Nasdaq (NDAQ) trade and settle in tokenized form on blockchain, combined with its Payward partnership, is drawing fresh attention to the stock’s role in digital assets. See our latest analysis for Nasdaq. Nasdaq’s recent tokenization announcements sit against a mixed share price backdrop, with a 6.06% 1 month share price return but a 10.68% decline year to date. At the same time, a 1...

Why Meitav Investment House Stock Is Back in Focus After Record 2025 Results Meitav Investment House (TASE:MTAV) is drawing fresh attention after reporting full year 2025 results that set records for revenue, profitability, and assets under management, along with a global equity raise backed by international institutions. The company reported 2025 revenue of ₪2,010 million versus ₪1,619 million a year earlier, with net income of ₪843 million compared with ₪256 million. Basic earnings per...

Skyworks Solutions (NasdaqGS:SWKS) and Qorvo have agreed to merge, bringing together two long time rivals in radio frequency chip manufacturing. The companies plan to combine their product portfolios for mobile devices and connectivity solutions, subject to regulatory and shareholder approvals. The announcement reflects a move toward greater scale and broader customer coverage in key wireless and connectivity markets. For you as an investor, this merger brings two established radio...

What recent returns say about Constellation Brands today Constellation Brands (STZ) has seen a 1.5% decline over the past day and a small loss over the past week, while the share price shows a larger decline over the past year. At a recent close of US$149.62, the stock is down about 4% over the past month but up roughly 11% in the past 3 months. This gives investors mixed short-term and more recent longer-period performance signals. See our latest analysis for Constellation Brands. The recent...

Novo Nordisk (NYSE:NVO) has received two recent FDA warnings related to its GLP-1 franchise. The company is experiencing rising GLP-1 competition from Eli Lilly and newer entrants such as Pfizer. These developments are emerging as revenue growth slows and margins come under pressure. Novo Nordisk, best known for its diabetes and obesity treatments, now finds its GLP-1 leadership under closer regulatory and competitive scrutiny. While recent attention has focused on valuation and telehealth...

European cloud infrastructure providers have filed a competition complaint with the EU against Broadcom (NasdaqGS:AVGO) over recent VMware licensing changes. The complaint, brought by industry group CISPE, alleges abuse of market position through the termination of prior VMware partner programs and tougher new license terms. Complainants are asking the European Commission to impose interim measures to halt the alleged practices and restore access to earlier partner arrangements. For...

Viatris (VTRS) has drawn fresh attention after announcing an Investor Event where leaders plan to lay out the company’s vision through 2030, including growth drivers, pipeline plans, portfolio choices, and capital return priorities. See our latest analysis for Viatris. Viatris shares currently trade at US$13.20, with a 30-day share price return of 17.76% decline, a 90-day share price return of 10.65%, and a 1-year total shareholder return of 50.99%. If the Investor Event has you thinking...

Tutor Perini (TPC) has drawn investor attention after recent share price swings, including a 4.1% decline over the past day and a 14.5% drop over the past month, despite solid reported profitability and revenue. See our latest analysis for Tutor Perini. The recent 1 day share price return of 4.1% decline and 30 day share price return of 14.5% decline sit in sharp contrast to a very large 1 year total shareholder return. This suggests momentum has cooled after a strong run as investors...

Why CCL Industries is on investors’ radar today CCL Industries (TSX:CCL.B) is back in focus after recent share price softness, with the stock showing negative returns over the past week, month, and past 3 months despite a positive 1 year total return. See our latest analysis for CCL Industries. At around CA$83.60, the recent 3.2% 7 day and 4% month share price declines contrast with a 19% 1 year total shareholder return. This suggests some momentum has cooled after a solid longer term run. If...

Hammond Power Solutions (TSX:HPS.A) just wrapped up FY 2025 with fourth quarter revenue of $254.1 million and basic EPS of $1.28, alongside trailing twelve month EPS of $6.07 on revenue of $898.3 million. Over recent periods, revenue has moved from $208.5 million in Q4 2024 to $254.1 million in Q4 2025, while quarterly EPS has shifted from $1.99 to $1.28. This sets up a picture where top line scale and reported profit growth sit next to a net margin line that investors will be watching...

Kangda International Environmental (SEHK:6136) has just posted its FY 2025 first half results, with revenue of C¥1.2b and basic EPS of C¥0.05, against a backdrop of 41.2% year over year earnings growth on a trailing twelve month basis. Over recent periods the company has seen revenue move from C¥1.1b in 1H 2024 to C¥1.2b in 2H 2024 and C¥1.2b in 1H 2025. Basic EPS has ranged between C¥0.03 and C¥0.05 across those halves as trailing EPS reached C¥0.11. With trailing net margins at 9.8%...

In recent weeks, Guardant Health and Helio Genomics each announced agreements with Quest Diagnostics to distribute their blood-based colorectal and liver cancer screening tests through Quest’s nationwide network, while the Quest board also appointed experienced healthcare executive Timothy Wentworth as a new director. Together, these moves deepen Quest’s role as an access point for innovative cancer detection while adding boardroom expertise in scaling complex healthcare platforms and...

Aveanna Healthcare Holdings (NasdaqGS:AVAH) announced the acquisition of Family First Homecare. The deal is intended to strengthen Aveanna's position in Florida and widen its geographic reach. The company also outlined a transformation that increased preferred payer agreements and set new M&A priorities for 2026. Aveanna Healthcare focuses on home based care services, an area many investors watch as care delivery shifts closer to the home. By adding Family First Homecare, the company is...

China Everbright Environment Group (SEHK:257) has just posted its FY 2025 first half numbers, reporting revenue of HK$14.3b and net income of HK$2.2b, equivalent to basic EPS of HK$0.36, alongside year over year earnings growth of 16.2%. The company has seen revenue move from HK$15.6b in 1H 2024 to HK$14.3b in 1H 2025 while basic EPS shifted from HK$0.40 to HK$0.36 over the same period. This sets the backdrop for a current net profit margin of 14.3% compared with 11.2% a year earlier. For...

Investors may be wondering if EchoStar at around US$109.84 is still offering value after its substantial rise, or if most of the easier gains are already behind it. The stock has delivered a 315.1% return over the last year, even with a 4.4% decline over the past month and a 2.1% decline year to date. This can change how the market views its risk and reward trade off. Recent coverage has focused on EchoStar's sharp multi year share price gains and what that means for current holders and new...

In recent months, Robert Half reported quarterly revenue of US$1.30 billion, a 5.8% decline year on year, yet still ahead of analyst expectations, while earnings per share also surpassed forecasts. This mixed picture, set against years of sluggish long‑term growth and falling earnings per share, has intensified investor focus on how effectively the company can adapt its talent and consulting model as AI and digital pressures build. We’ll now examine how the revenue decline alongside an...

If you are wondering whether Ørsted at a last close of 138.0 is a bargain or a value trap, the key is understanding how different valuation methods line up on the stock. The share price has seen mixed performance, with a 7.8% return year to date contrasting with a 24.3% decline over the last year and a 54.7% and 74.6% decline over the past 3 and 5 years respectively. This can change how investors think about both risk and potential upside. Recent coverage around Ørsted has focused on its...

Geopolitical tensions in the Middle East, along with the related jump in energy prices, have put industrial stocks in focus again, with Curtiss-Wright (CW) drawing attention as investors reassess cost pressures and economic sensitivities. See our latest analysis for Curtiss-Wright. Curtiss-Wright’s share price has been volatile around geopolitical headlines, with a 1-day share price return of a 2.95% decline, a 90-day share price return of 20.96%, and a 1-year total shareholder return of...

If you are wondering whether Enerpac Tool Group at around US$35.97 is a bargain, fairly priced, or looking stretched, this article walks through the key valuation angles to help you frame that question clearly. The stock is roughly flat over the last week with a 0.3% return. That sits against a 14.7% decline over the last month and a 14.8% decline over the last year, even as the 3 year and 5 year returns are 37.7% and 38.0% respectively. Recent coverage has focused on how Enerpac Tool Group...

Sun.King Technology Group (SEHK:580) has reported FY 2025 first half revenue of C¥888.3 million and basic EPS of C¥0.058, with trailing 12 month revenue at about C¥2.3 billion and basic EPS of C¥0.086 alongside a 34.5% earnings gain over the past year and earnings forecast to grow around 32.1% per year. The company has seen revenue move from C¥655.8 million and basic EPS of C¥0.021 in 1H FY 2024 to C¥954.5 million and C¥0.043 in 2H FY 2024, and then to C¥888.3 million and C¥0.058 in 1H FY...